Erika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated. The treatment, called Amtagvi, from Iovance Biotherapeutics, is for metastatic melanoma patients who have already tried and failed other drugs. It’s known as TIL therapy and involves boosting the number of immune cells inside tumors, harnessing their power to fight the cancer.
Steven Rosenberg, chief of the surgery branch at the National Cancer Institute. “They’re a small price to pay for a growing cancer that would otherwise be lethal.” Overall, Dahut said the approval of TIL therapy is “meaningful.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
CDC hasn't changed Covid guidelines yet: Here’s what you need to knowErika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
Weiterlesen »
CDC may recommend some people get a new Covid booster this springErika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
Weiterlesen »
'The voice we woke up to': Bob Edwards, longtime 'Morning Edition' host, dies at 76Edwards, a consummate newsman, hosted NPR's morning show for more than two decades. 'He sort of set the tone and the bar for all of us,' says one former NPR executive.
Weiterlesen »
Charles Edwards Unveils Golden Bitcoin Buying Opportunity Amid BTC HalvingCharles Edwards names best time to get into BTC amid Bitcoin halving
Weiterlesen »
Ryan Edwards' Girlfriend Amanda Conner Lost Custody of Her Son Because of 'Neglect'Amanda Conner, current girlfriend of 'Teen Mom' star Ryan Edwards, lost custody of her child after going through a divorce.
Weiterlesen »
Democrat Tom Suozzi wins George Santos' House seat, NBC News projectsThis is additional taxonomy that helps us with analytics
Weiterlesen »